Xenical/Orlistat Capsules

Company
Roche

Approval Status
Approved April 1999

Treatment for
Endocrinology

Areas
Diabetes / Endocrinology

Xenical/Orlistat Capsules, 120 mg, a lipase inhibitor, have been approved for obesity management. Xenical acts by inhibiting the absorption of dietary fats.

Xenical_orlistat_capsules Drug Information

The Xenical_orlistat_capsules drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top